Druggable	Report_C1	Report_C2	Tumor_VAF	Normal_VAF	DP_T	DP_N	SF_TVAF	SF_TDP	CHROM	Start	End	REF	ALT	FILTER	Gene	Transcript	Exon/Intron_Number	cHGVS	pHGVS	Type_Annotation	CLNSIG	CLNCONF	CLNDN	COSMIC	Related_Results
	SPEN(34.1%)	exon11,c.2909C>T,p.A970V	0.341	0.333	26|15	3|1	0.34043	31|16	1	16255644	16255644	C	T	germline,normal_artifact,Germline	SPEN	NM_015001.3	11	c.2909C>T	p.Ala970Val	missense_variant	Benign		SPEN-related_condition|not_provided		
-	ARID1A(2.5%)	exon20,c.5548del,p.D1850fs	0.025	0.025	288|7	41|0	0.02247	348|8	1	27105930	27105931	TG	T	suspected_bg	ARID1A	NM_006015.6	20	c.5548del	p.Asp1850fs	frameshift_variant					
	MPL(1.1%)	exon3,c.231C>T,p.C77=	0.011	0.027	665|6	89|1	0.01008	786|8	1	43804231	43804231	C	T	normal_artifact	MPL	NM_005373.3	3	c.231C>T	p.Cys77=	synonymous_variant	Likely_benign		Congenital_amegakaryocytic_thrombocytopenia|Essential_thrombocythemia		
	DPYD(0.3%)	exon13,c.1651G>A,p.A551T	0.002603	0.002782	11848|32	3055|9	0.00294	43110|127	1	97981371	97981371	C	T	normal_artifact,low_allele_frac,chemotherapy_site	DPYD	NM_000110.4	13	c.1651G>A	p.Ala551Thr	missense_variant	Conflicting_classifications_of_pathogenicity	Likely_pathogenic(3)|Uncertain_significance(3)	Dihydropyrimidine_dehydrogenase_deficiency|DPYD-related_disorder|not_provided		
	DPYD(0.2%)	exon13,c.1635T>C,p.P545=	0.002217	0.001245	12373|40	3171|7	0.00235	47158|111	1	97981387	97981387	A	G	low_allele_frac,chemotherapy_site	DPYD	NM_000110.4	13	c.1635T>C	p.Pro545=	synonymous_variant					
1	NRAS(0.1%)	exon4,c.437C>T,p.A146V	0.001127	0.002347	11226|11	2072|5	0.00070	28417|20	1	115252203	115252203	G	A	normal_artifact,orientation,weak_evidence	NRAS	NM_002524.5	4	c.437C>T	p.Ala146Val	missense_variant				COSV65746912	
	LORICRIN(1.3%)	exon2,c.69_188del,p.G24_G63del	0.013	0.035	370|4	28|0	1.00000	0|4	1	153233481	153233601	CCTCTGGCGGCGGTGGCGGTGGCGGCGGCAGCGGCGGTGGTGGCTGCGGCTTCTTCGGCGGCGGCGGCTCAGGGGGCGGTAGCAGCGGTTCTGGCTGCGGCTACTCCGGCGGCGGTGGCTA	C	PASS	LORICRIN	NM_000427.3	2	c.69_188del	p.Gly24_Gly63del	disruptive_inframe_deletion					
	NTRK1(0.7%)	exon15,c.1955C>T,p.A652V	0.006609	0.004802	1754|12	257|2	0.00904	2301|21	1	156849063	156849063	C	T	low_allele_frac	NTRK1	NM_002529.4	15	c.1955C>T	p.Ala652Val	missense_variant				COSV62326448	
	SPTA1(23.6%)	exon49,c.6794T>C,p.I2265T	0.236	0.528	32|8	1|1	0.22414	45|13	1	158584091	158584091	A	G	germline,normal_artifact,Germline	SPTA1	NM_003126.4	49	c.6794T>C	p.Ile2265Thr	missense_variant	Benign		not_specified|not_provided|Elliptocytosis_2|Pyropoikilocytosis,_hereditary|Hereditary_spherocytosis_type_3		
	PIK3C2B(24.9%)	exon21,c.3023G>A,p.R1008Q	0.249	0.471	20|6	1|1	0.23077	20|6	1	204412570	204412570	C	T	germline,normal_artifact	PIK3C2B	NM_002646.4	21	c.3023G>A	p.Arg1008Gln	missense_variant				COSV65809867	
	IKBKE(37.5%)	exon22,c.2138C>T,p.P713L	0.375	0.4	7|4	3|1	0.36364	7|4	1	206669465	206669465	C	T	germline,normal_artifact	IKBKE	NM_014002.4	22	c.2138C>T	p.Pro713Leu	missense_variant				COSV65622766	
	H3-3A(2.6%)	exon4,c.344C>G,p.A115G	0.026	0.025	416|11	48|0	0.06475	520|36	1	226259113	226259113	C	G	strand_bias,background	H3-3A	NM_002107.7	4	c.344C>G	p.Ala115Gly	missense_variant				COSV64731809	
	FMN2(1.3%)	exon5,c.2772_2837del,p.P925_P946del	0.013	0.034	699|10	68|2	0.00000	36|0	1	240370869	240370935	CATACCTCCTCCGCCGCCTCTACCCGGAGCAGGCATACTCCCTCTGCCCCCTCTACCCGGAGCGGGA	C	normal_artifact	FMN2	NM_020066.5	5	c.2772_2837del	p.Pro925_Pro946del	disruptive_inframe_deletion					
	MYCN(1.1%)	exon2,c.134del,p.P45fs	0.011	0.014	1352|21	179|2	0.01407	1892|27	2	16082313	16082314	AC	A	suspected_bg	MYCN	NM_005378.6	2	c.134del	p.Pro45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Feingold_syndrome_type_1|not_provided		
	ALK(1.0%)	exon3,c.875G>A,p.R292H	0.009958	0.00396	1979|20	304|0	0.00893	2775|25	2	29917793	29917793	C	T	background	ALK	NM_004304.5	3	c.875G>A	p.Arg292His	missense_variant	Conflicting_classifications_of_pathogenicity	Uncertain_significance(2)|Likely_benign(1)	Neuroblastoma,_susceptibility_to,_3|Hereditary_cancer-predisposing_syndrome		
-	MSH2(2.6%)	exon2,c.212-5_212-4del	0.026	0.016	1098|45	147|2	0.02414	2547|63	2	47635523	47635525	CTT	C	clustered_events,multiallelic,normal_artifact	MSH2	NM_000251.3	2	c.212-5_212-4del		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified		
-	MSH2(16.0%)	exon2,c.212-4del	0.16	0.17	1098|287	147|40	0.16382	2547|499	2	47635523	47635525	CTT	CT	clustered_events,multiallelic,normal_artifact,suspected_bg	MSH2	NM_000251.3	2	c.212-4del		splice_region_variant&intron_variant	Benign/Likely_benign		not_specified|Hereditary_cancer-predisposing_syndrome|not_provided|Lynch_syndrome_1		
-	MSH2(7.6%)	exon2,c.212-4dup	0.076	0.09	1098|154	147|20	0.11130	2547|319	2	47635523	47635525	CTT	CTTT	clustered_events,multiallelic,normal_artifact,suspected_bg	MSH2	NM_000251.3	2	c.212-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|Breast_and/or_ovarian_cancer|not_provided|Hereditary_cancer-predisposing_syndrome		
-	MSH2(1.2%)	exon2,c.212-4T>A	0.012	0.019	1828|30	241|9	0.02147	3828|84	2	47635536	47635536	T	A	clustered_events,haplotype,normal_artifact,background	MSH2	NM_000251.3	2	c.212-4T>A		splice_region_variant&intron_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms		
-	MSH6(4.6%)	exon5,c.3261del,p.F1088fs	0.046	0.061	5231|306	771|56	0.04433	9615|446	2	48030639	48030640	AC	A	normal_artifact,slippage,suspected_bg	MSH6	NM_000179.3	5	c.3261del	p.Phe1088fs	frameshift_variant	Pathogenic		Endometrial_carcinoma|Lynch_syndrome_5|Mismatch_repair_cancer_syndrome_3|Lynch_syndrome|Lynch-like_syndrome|Hereditary_nonpolyposis_colorectal_neoplasms|Hereditary_cancer-predisposing_syndrome|not_provided|Gastric_cancer|Carcinoma_of_colon		
	CLASP1(3.0%)	exon35,c.3692del,p.G1231fs	0.03	0.014	716|27	156|1	0.02750	1061|30	2	122125357	122125358	AC	A	background	CLASP1	NM_015282.3	35	c.3692del	p.Gly1231fs	frameshift_variant					
	LRP1B(1.3%)	exon27,c.4466C>A,p.T1489N	0.013	0.007053	1004|13	175|0	0.01399	1198|17	2	141625272	141625272	G	T	PASS	LRP1B	NM_018557.3	27	c.4466C>A	p.Thr1489Asn	missense_variant					
	PRKRA(28.4%)	exon1,c.22_23del,p.A8fs	0.284	0.333	27|8	1|0	0.42623	35|26	2	179315734	179315736	GGC	G	germline,Germline	PRKRA	NM_003690.5	1	c.22_23del	p.Ala8fs	frameshift_variant	Benign/Likely_benign		not_provided|not_specified|Nonsyndromic_Hearing_Loss,_Recessive|Dystonic_disorder|Dystonia_16		
1	IDH1(0.1%)	exon4,c.394C>T,p.R132C	0.0008358	0.002104	6036|5	1112|1	0.00071	11262|8	2	209113113	209113113	G	A	orientation,weak_evidence	IDH1	NM_005896.4	4	c.394C>T	p.Arg132Cys	missense_variant	Pathogenic/Likely_pathogenic		Enchondromatosis|Maffucci_syndrome|not_provided|Myelodysplastic_syndrome|Breast_neoplasm|Adenoid_cystic_carcinoma|Prostate_adenocarcinoma|Neoplasm_of_the_large_intestine|Medulloblastoma|Hepatocellular_carcinoma|Astrocytoma|Glioma_susceptibility_1|Brainstem_glioma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_brain|Lung_adenocarcinoma|Glioblastoma|Malignant_melanoma_of_skin|Acute_myeloid_leukemia|Multiple_myeloma		
	ERBB4(10.3%)	exon13,c.1571G>A,p.R524H	0.103	0.009043	1146|124	129|0	0.10189	1472|167	2	212543828	212543828	C	T	PASS	ERBB4	NM_005235.3	13	c.1571G>A	p.Arg524His	missense_variant	Conflicting_classifications_of_pathogenicity	Uncertain_significance(1)|Likely_benign(1)	not_provided		
	UGT1A1(0.9%)	exon0,c.-55_-54insAT	0.008765	0.007268	8858|104	1624|17	0.00860	26624|231	2	234668879	234668883	CATAT	CATATAT	clustered_events,multiallelic,normal_artifact,suspected_bg,chemotherapy_site	UGT1A1	NM_000463.3	0	c.-55_-54insAT		upstream_gene_variant	Conflicting_classifications_of_pathogenicity|drug_response|other	Pathogenic(7)|Likely_pathogenic(1)|Uncertain_significance(2)|Benign(2)	Crigler-Najjar_syndrome_type_1|Gilbert_syndrome|Bilirubin,_serum_level_of,_quantitative_trait_locus_1|Lucey-Driscoll_syndrome|Crigler-Najjar_syndrome,_type_II|Irinotecan_response|not_specified|not_provided		
2	FANCD2(7.6%)	exon6,c.378-5del	0.076	0.054	1159|106	225|11	0.07927	1661|143	3	10076842	10076843	CT	C	multiallelic,normal_artifact,slippage,suspected_bg	FANCD2	NM_001018115.3	6	c.378-5del		splice_region_variant&intron_variant					
2	FANCD2(4.6%)	exon6,c.378-5dup	0.046	0.056	1159|73	225|18	0.05679	1661|100	3	10076842	10076843	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	FANCD2	NM_001018115.3	6	c.378-5dup		splice_region_variant&intron_variant					
	TGFBR2(9.5%)	exon4,c.458del,p.K153fs	0.095	0.088	1114|132	193|23	0.08168	1664|148	3	30691871	30691872	GA	G	multiallelic,normal_artifact,slippage,suspected_bg	TGFBR2	NM_001024847.2	4	c.458del	p.Lys153fs	frameshift_variant	Conflicting_classifications_of_pathogenicity	Likely_pathogenic(1)|Uncertain_significance(1)|Benign(2)|Likely_benign(1)	not_provided|Loeys-Dietz_syndrome|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified		
	ANO10(3.4%)	exon2,c.132del,p.D45fs	0.034	0.045	3789|164	718|41	0.04300	6765|304	3	43647212	43647213	CT	C	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132del	p.Asp45fs	frameshift_variant	Pathogenic		not_provided		
	ANO10(2.3%)	exon2,c.132dup,p.D45fs	0.023	0.03	3789|124	718|26	0.03619	6765|254	3	43647212	43647213	CT	CTT	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	ANO10	NM_018075.5	2	c.132dup	p.Asp45fs	frameshift_variant	Pathogenic/Likely_pathogenic		Autosomal_recessive_spinocerebellar_ataxia_10|not_provided|Autosomal_recessive_cerebellar_ataxia|Abnormal_central_motor_function		
	SETD2(1.3%)	exon15,c.6656C>T,p.A2219V	0.013	0.019	721|9	131|2	0.01308	830|11	3	47098618	47098618	G	A	normal_artifact	SETD2	NM_014159.7	15	c.6656C>T	p.Ala2219Val	missense_variant					
	PBRM1(1.2%)	exon23,c.3468A>G,p.K1156=	0.012	0.028	513|6	82|1	0.00972	611|6	3	52610705	52610705	T	C	haplotype,normal_artifact	PBRM1	NM_018313.5	23	c.3468A>G	p.Lys1156=	synonymous_variant					
	FOXP1(1.7%)	exon13,c.985A>G,p.S329G	0.017	0.029	312|5	41|0	0.01279	386|5	3	71050200	71050200	T	C	PASS	FOXP1	NM_032682.6	13	c.985A>G	p.Ser329Gly	missense_variant					
	PIK3CB(2.1%)	exon5,c.468C>T,p.S156=	0.021	0.017	426|8	73|0	0.01587	496|8	3	138461553	138461553	G	A	PASS	PIK3CB	NM_006219.3	5	c.468C>T	p.Ser156=	synonymous_variant				COSV104610812	
	ATR(2.0%)	exon45,c.7534C>T,p.P2512S	0.02	0.02	452|8	53|0	0.01501	525|8	3	142176567	142176567	G	A	distinguished	ATR	NM_001184.4	45	c.7534C>T	p.Pro2512Ser	missense_variant				COSV100637832	
	ATR(7.2%)	exon10,c.2320del,p.I774fs	0.072	0.065	7673|727	1522|135	0.06703	18012|1294	3	142274739	142274740	AT	A	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	ATR	NM_001184.4	10	c.2320del	p.Ile774fs	frameshift_variant	Pathogenic		Endometrium_neoplasm|not_provided		
	ATR(2.4%)	exon10,c.2320dup,p.I774fs	0.024	0.032	7673|270	1522|67	0.04303	18012|810	3	142274739	142274740	AT	ATT	clustered_events,multiallelic,normal_artifact,slippage,background	ATR	NM_001184.4	10	c.2320dup	p.Ile774fs	frameshift_variant	Pathogenic/Likely_pathogenic		not_provided|Seckel_syndrome_1		
	PIK3CA(7.3%)	exon14,c.2028C>T,p.H676=	0.073	0.003811	1896|140	342|0	0.06303	2676|180	3	178938786	178938786	C	T	PASS	PIK3CA	NM_006218.4	14	c.2028C>T	p.His676=	synonymous_variant	Likely_benign		Cowden_syndrome|Inborn_genetic_diseases		
	FGFR3(2.9%)	exon9,c.1206del,p.K403fs	0.029	0.015	357|12	71|0	0.02908	601|18	4	1806180	1806181	GC	G	suspected_bg	FGFR3	NM_000142.5	9	c.1206del	p.Lys403fs	frameshift_variant					
	FGFR3(2.2%)	exon15,c.1979G>T,p.W660L	0.022	0.022	436|10	98|2	0.00506	590|3	4	1808003	1808003	G	T	clustered_events,normal_artifact,orientation,strand_bias,distinguished	FGFR3	NM_000142.5	15	c.1979G>T	p.Trp660Leu	missense_variant					
	PDGFRA(0.3%)	exon18,c.2458G>A,p.A820T	0.003383	0.003517	5580|25	1186|3	0.00310	10619|33	4	55152026	55152026	G	A	low_allele_frac	PDGFRA	NM_006206.6	18	c.2458G>A	p.Ala820Thr	missense_variant				COSV57267206	
	KIT(0.6%)	exon7,c.1149del,p.G384fs	0.006311	0.005281	4384|42	696|2	0.00731	6929|51	4	55575619	55575620	TA	T	low_allele_frac	KIT	NM_000222.3	7	c.1149del	p.Gly384fs	frameshift_variant					
	INPP4B(1.3%)	exon13,c.852A>G,p.K284=	0.013	0.029	544|6	85|1	0.00935	636|6	4	143130164	143130164	T	C	normal_artifact	INPP4B	NM_001101669.3	13	c.852A>G	p.Lys284=	synonymous_variant					
	FBXW7(19.6%)	exon9,c.1379A>G,p.H460R	0.196	0.01	495|127	118|0	0.20341	607|155	4	153249399	153249399	T	C	PASS	FBXW7	NM_033632.3	9	c.1379A>G	p.His460Arg	missense_variant				COSV55901947	
-	FBXW7(24.0%)	exon4,c.585-5del	0.24	0.237	14|5	4|1	0.20455	35|9	4	153268227	153268229	CAA	CA	germline,multiallelic,normal_artifact,suspected_bg	FBXW7	NM_033632.3	4	c.585-5del		splice_region_variant&intron_variant					
-	FBXW7(9.9%)	exon4,c.585-4G>T	0.099	0.092	14|4	4|0	0.27083	35|13	4	153268227	153268227	C	A	germline,multiallelic,normal_artifact,suspected_bg	FBXW7	NM_033632.3	4	c.585-4G>T		splice_region_variant&intron_variant					
	FAT1(1.0%)	exon9,c.4671C>T,p.D1557=	0.009693	0.007502	761|8	148|0	0.00875	906|8	4	187549447	187549447	G	A	PASS	FAT1	NM_005245.4	9	c.4671C>T	p.Asp1557=	synonymous_variant					
	SDHA(8.9%)	exon15,c.1974G>C,p.P658=	0.089	0.043	352|34	36|1	0.11364	390|50	5	256514	256514	G	C	background	SDHA	NM_004168.4	15	c.1974G>C	p.Pro658=	synonymous_variant	Benign/Likely_benign		not_specified|not_provided|Leigh_syndrome|Hereditary_pheochromocytoma-paraganglioma|Mitochondrial_complex_II_deficiency,_nuclear_type_1|Hereditary_cancer-predisposing_syndrome|Paragangliomas_5		
	IL7R(1.8%)	exon6,c.799del,p.R267fs	0.018	0.011	1579|34	204|2	0.01857	2167|41	5	35874636	35874637	GA	G	suspected_bg	IL7R	NM_002185.5	6	c.799del	p.Arg267fs	frameshift_variant&splice_region_variant					
	RICTOR(4.2%)	exon30,c.3116C>G,p.S1039C	0.042	0.00253	3326|148	469|0	0.04559	5150|246	5	38952309	38952309	G	C	PASS	RICTOR	NM_152756.5	30	c.3116C>G	p.Ser1039Cys	missense_variant					
-	PIK3R1(1.3%)	exon2,c.244del,p.I82fs	0.013	0.019	378|5	61|0	0.01423	485|7	5	67522740	67522741	GA	G	background	PIK3R1	NM_181523.3	2	c.244del	p.Ile82fs	frameshift_variant					
	MSH3(1.6%)	exon7,c.1148del,p.K383fs	0.016	0.016	6661|135	1269|28	0.01762	13600|244	5	79970914	79970915	CA	C	multiallelic,normal_artifact,slippage,suspected_bg	MSH3	NM_002439.5	7	c.1148del	p.Lys383fs	frameshift_variant	Pathogenic/Likely_pathogenic		MSH3-related_disorder|Endometrial_carcinoma|Familial_adenomatous_polyposis_4|not_provided|Hereditary_cancer-predisposing_syndrome		
	MSH3(2.1%)	exon7,c.1148dup,p.N385fs	0.021	0.013	6661|191	1269|25	0.02558	13600|357	5	79970914	79970915	CA	CAA	multiallelic,normal_artifact,slippage,background	MSH3	NM_002439.5	7	c.1148dup	p.Asn385fs	frameshift_variant	Pathogenic/Likely_pathogenic		not_provided|Endometrial_carcinoma|Familial_adenomatous_polyposis_4|Hereditary_cancer-predisposing_syndrome		
	MSH3(0.3%)	exon7,c.1149G>A,p.K383=	0.002961	0.002924	7252|31	1385|4	0.00474	14490|69	5	79970923	79970923	G	A	low_allele_frac	MSH3	NM_002439.5	7	c.1149G>A	p.Lys383=	synonymous_variant	Likely_benign		not_specified|Hereditary_cancer-predisposing_syndrome|not_provided		
-	APC(12.0%)	exon5,c.423-4del	0.12	0.113	643|118	113|21	0.13752	1085|173	5	112111309	112111310	TA	T	multiallelic,normal_artifact,slippage,suspected_bg	APC	NM_000038.6	5	c.423-4del		splice_region_variant&intron_variant	Benign		Hereditary_cancer-predisposing_syndrome|Desmoid_disease,_hereditary|Familial_adenomatous_polyposis_1|Gastric_adenocarcinoma_and_proximal_polyposis_of_the_stomach|Hepatocellular_carcinoma|Colorectal_cancer|Gastric_cancer|APC-related_disorder|not_specified|not_provided		
-	APC(8.6%)	exon5,c.423-4dup	0.086	0.098	643|94	113|16	0.11356	1085|139	5	112111309	112111310	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	APC	NM_000038.6	5	c.423-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		not_specified|Familial_adenomatous_polyposis_1|Hereditary_cancer-predisposing_syndrome|Gastric_adenocarcinoma_and_proximal_polyposis_of_the_stomach|Colorectal_cancer|Desmoid_disease,_hereditary|Hepatocellular_carcinoma|Gastric_cancer		
	APC(0.3%)	exon16,c.5887T>C,p.F1963L	0.002869	0.002175	3289|10	541|0	0.00253	4734|12	5	112177178	112177178	T	C	low_allele_frac	APC	NM_000038.6	16	c.5887T>C	p.Phe1963Leu	missense_variant					
	RAD50(5.2%)	exon13,c.2165del,p.K722fs	0.052	0.068	11280|762	2317|194	0.05041	38482|2043	5	131931451	131931452	TA	T	clustered_events,multiallelic,normal_artifact,background	RAD50	NM_005732.4	13	c.2165del	p.Lys722fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome		
	RAD50(1.7%)	exon13,c.2165dup,p.E723fs	0.017	0.009842	11280|289	2317|34	0.03117	38482|1238	5	131931451	131931452	TA	TAA	clustered_events,multiallelic,normal_artifact,suspected_bg	RAD50	NM_005732.4	13	c.2165dup	p.Glu723fs	frameshift_variant	Pathogenic		Nijmegen_breakage_syndrome-like_disorder|Hereditary_cancer-predisposing_syndrome|Breast_and/or_ovarian_cancer|not_provided		
	CSF1R(56.8%)	exon5,c.726C>T,p.T242=	0.568	0.126	38|46	9|0	0.53933	41|48	5	149457678	149457678	G	A	germline,Germline	CSF1R	NM_005211.4	5	c.726C>T	p.Thr242=	synonymous_variant	Benign		Hereditary_diffuse_leukoencephalopathy_with_spheroids|Brain_abnormalities,_neurodegeneration,_and_dysosteosclerosis|not_provided		
	NSD1(1.3%)	exon23,c.6472G>A,p.E2158K	0.013	0.033	433|6	70|1	0.01183	501|6	5	176720841	176720841	G	A	normal_artifact	NSD1	NM_022455.5	23	c.6472G>A	p.Glu2158Lys	missense_variant					
	IRF4(90.0%)	exon2,c.207G>C,p.A69=	0.9	0.667	0|11	0|1	1.00000	0|11	6	393359	393359	G	C	germline,haplotype,normal_artifact	IRF4	NM_002460.4	2	c.207G>C	p.Ala69=	synonymous_variant	Benign		not_provided		
	FANCE(97.6%)	exon2,c.387A>C,p.P129=	0.976	0.8	0|44	0|3	1.00000	0|56	6	35423662	35423662	A	C	germline,normal_artifact,Germline	FANCE	NM_021922.3	2	c.387A>C	p.Pro129=	synonymous_variant	Benign		not_provided|Fanconi_anemia_complementation_group_E|not_specified		
	CCND3(66.2%)	exon5,c.775T>G,p.S259A	0.662	0.482	13|34	3|3	0.70370	16|38	6	41903782	41903782	A	C	germline,normal_artifact,Germline	CCND3	NM_001760.5	5	c.775T>G	p.Ser259Ala	missense_variant				COSV57827647	
	EPHA7(8.7%)	exon10,c.1803A>C,p.K601N	0.087	0.004936	1341|121	267|0	0.08463	1709|158	6	93969193	93969193	T	G	chemotherapy_site	EPHA7	NM_004440.4	10	c.1803A>C	p.Lys601Asn	missense_variant					
	EPHA7(0.9%)	exon3,c.745C>T,p.H249Y	0.008955	0.012	749|7	185|1	0.00715	972|7	6	94120306	94120306	G	A	chemotherapy_site	EPHA7	NM_004440.4	3	c.745C>T	p.His249Tyr	missense_variant				COSV65169603	
	TNFAIP3(1.5%)	exon9,c.2097C>T,p.S699=	0.015	0.032	474|6	36|0	0.01408	560|8	6	138202180	138202180	C	T	PASS	TNFAIP3	NM_006290.4	9	c.2097C>T	p.Ser699=	synonymous_variant					
	ARID1B(50.0%)	exon1,c.609_611dup,p.Q204dup	0.5	0.5	4|4	0|0	0.50000	5|5	6	157099402	157099402	C	CCAG	germline,haplotype,slippage	ARID1B	NM_001374828.1	1	c.609_611dup	p.Gln204dup	disruptive_inframe_insertion	Benign/Likely_benign		ARID1B-related_disorder|Inborn_genetic_diseases|not_specified|not_provided		
	ARID1B(3.5%)	exon20,c.5792G>A,p.R1931H	0.035	0.042	136|4	26|0	0.03205	151|5	6	157527698	157527698	G	A	PASS	ARID1B	NM_001374828.1	20	c.5792G>A	p.Arg1931His	missense_variant	Likely_benign		not_provided		
	ARID1B(0.7%)	exon20,c.6174G>A,p.A2058=	0.007135	0.011	987|8	118|0	0.00857	1157|10	6	157528080	157528080	G	A	low_allele_frac	ARID1B	NM_001374828.1	20	c.6174G>A	p.Ala2058=	synonymous_variant	Likely_benign		ARID1B-related_disorder|Inborn_genetic_diseases		
	CARD11(85.7%)	exon25,c.3276A>G,p.R1092=	0.857	0.5	0|5	0|0	1.00000	0|5	7	2946461	2946461	T	C	germline	CARD11	NM_032415.7	25	c.3276A>G	p.Arg1092=	synonymous_variant	Benign		BENTA_disease|Severe_combined_immunodeficiency_due_to_CARD11_deficiency|not_specified|Immunodeficiency_11b_with_atopic_dermatitis|not_provided		
2	PMS2(45.5%)	exon12,c.2007-4G>A	0.455	0.231	86|64	11|3	0.47849	97|89	7	6022626	6022626	C	T	germline,normal_artifact,Germline	PMS2	NM_000535.7	12	c.2007-4G>A		splice_region_variant&intron_variant	Benign		Hereditary_cancer-predisposing_syndrome|not_specified|Lynch_syndrome_4|Endometrial_carcinoma|not_provided|Lynch_syndrome|Lynch_syndrome_1|Hereditary_nonpolyposis_colorectal_neoplasms		
	PMS2(0.2%)	exon11,c.1635T>C,p.S545=	0.001502	0.001016	11279|23	2076|2	0.00174	25771|45	7	6026761	6026761	A	G	low_allele_frac	PMS2	NM_000535.7	11	c.1635T>C	p.Ser545=	synonymous_variant	Likely_benign		Hereditary_cancer-predisposing_syndrome		
2	PMS2(10.3%)	exon7,c.706-6_706-4del	0.103	0.134	170|124	14|21	0.08722	1957|187	7	6037057	6037060	GAAA	G	germline,multiallelic,normal_artifact	PMS2	NM_000535.7	7	c.706-6_706-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_nonpolyposis_colorectal_neoplasms|not_specified|Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|Malignant_tumor_of_breast|not_provided		
2	PMS2(22.7%)	exon7,c.706-5_706-4del	0.227	0.123	170|261	14|21	0.19630	1957|478	7	6037057	6037060	GAAA	GA	germline,multiallelic,normal_artifact	PMS2	NM_000535.7	7	c.706-5_706-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_nonpolyposis_colorectal_neoplasms|Lynch_syndrome_4|not_specified|Hereditary_cancer-predisposing_syndrome|PMS2-related_disorder|not_provided|Lynch_syndrome		
1	EGFR(0.1%)	exon20,c.2312A>C,p.N771T	0.0007938	0.005834	3090|19	489|6	0.00972	4482|44	7	55249014	55249014	A	C	base_qual,normal_artifact,strand_bias,weak_evidence,background	EGFR	NM_005228.5	20	c.2312A>C	p.Asn771Thr	missense_variant					
1	EGFR(0.1%)	exon20,c.2374C>T,p.L792F	0.001404	0.002672	3055|4	467|0	0.00091	4383|4	7	55249076	55249076	C	T	orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2374C>T	p.Leu792Phe	missense_variant	Uncertain_significance		EGFR-related_lung_cancer		
1	EGFR(0.3%)	exon20,c.2387G>A,p.G796D	0.002839	0.008028	2996|10	450|3	0.00278	4301|12	7	55249089	55249089	G	A	normal_artifact,orientation,weak_evidence	EGFR	NM_005228.5	20	c.2387G>A	p.Gly796Asp	missense_variant	Uncertain_significance		EGFR-related_lung_cancer		
1	EGFR(0.1%)	exon20,c.2389T>A,p.C797S	0.0009656	0.002824	2947|6	444|1	0.00260	4225|11	7	55249091	55249091	T	A	base_qual,orientation,strand_bias,weak_evidence	EGFR	NM_005228.5	20	c.2389T>A	p.Cys797Ser	missense_variant	Uncertain_significance		EGFR-related_lung_cancer|Non-small_cell_lung_carcinoma		
1	EGFR(0.1%)	exon21,c.2573T>G,p.L858R	0.0009817	0.002101	3710|7	632|1	0.00220	5442|12	7	55259515	55259515	T	G	base_qual,strand_bias,weak_evidence	EGFR	NM_005228.5	21	c.2573T>G	p.Leu858Arg	missense_variant	drug_response		Adenocarcinoma_of_lung,_response_to_tyrosine_kinase_inhibitor_in,_somatic|Tyrosine_kinase_inhibitor_response|Non-small_cell_lung_carcinoma|gefitinib_response_-_Efficacy|Lung_adenocarcinoma|Lung_carcinoma|Nonsmall_cell_lung_cancer,_response_to_tyrosine_kinase_inhibitor_in,_somatic		
	MAGI2(45.8%)	exon22,c.4329C>G,p.P1443=	0.458	0.666	15|14	0|1	0.45161	17|14	7	77648671	77648671	G	C	germline,normal_artifact,Germline	MAGI2	NM_012301.4	22	c.4329C>G	p.Pro1443=	synonymous_variant	Benign		not_specified|not_provided|Nephrotic_syndrome_15		
	MAGI2(95.5%)	exon19,c.3213G>A,p.S1071=	0.955	0.8	0|24	0|3	1.00000	0|33	7	77756724	77756724	C	T	germline,normal_artifact,Germline	MAGI2	NM_012301.4	19	c.3213G>A	p.Ser1071=	synonymous_variant	Benign		Nephrotic_syndrome_15|not_provided|not_specified		
	MAGI2(1.2%)	exon4,c.620C>T,p.A207V	0.012	0.017	419|5	72|1	0.01018	486|5	7	78150881	78150881	G	A	PASS	MAGI2	NM_012301.4	4	c.620C>T	p.Ala207Val	missense_variant					
	GRM3(1.5%)	exon3,c.1212G>A,p.L404=	0.015	0.017	540|8	66|0	0.01727	626|11	7	86416320	86416320	G	A	PASS	GRM3	NM_000840.3	3	c.1212G>A	p.Leu404=	synonymous_variant					
	MET(0.3%)	exon7,c.1867A>G,p.K623E	0.002643	0.001471	4971|12	881|0	0.00172	8139|14	7	116397495	116397495	A	G	low_allele_frac	MET	NM_000245.4	7	c.1867A>G	p.Lys623Glu	missense_variant					
1	BRAF(0.1%)	exon15,c.1801A>G,p.K601E	0.0007817	0.0009781	11287|8	2403|1	0.00054	31689|17	7	140453134	140453134	T	C	strand_bias,weak_evidence	BRAF	NM_004333.6	15	c.1801A>G	p.Lys601Glu	missense_variant	Pathogenic		Neoplasm|Malignant_melanoma_of_skin|Non-small_cell_lung_carcinoma|Carcinoma_of_colon|B-cell_chronic_lymphocytic_leukemia|Lung_adenocarcinoma|Thyroid_cancer,_nonmedullary,_2|Prostate_adenocarcinoma|Malignant_neoplasm_of_body_of_uterus|Melanoma|Thyroid_tumor|Gastric_adenocarcinoma		
	KEL(0.9%)	exon7,c.690T>C,p.F230=	0.009223	0.01	703|7	111|0	0.01009	785|8	7	142651597	142651597	A	G	PASS	KEL	NM_000420.3	7	c.690T>C	p.Phe230=	synonymous_variant					
	KEL(4.0%)	exon6,c.646G>A,p.A216T	0.04	0.061	180|6	19|0	0.03980	193|8	7	142654940	142654940	C	T	PASS	KEL	NM_000420.3	6	c.646G>A	p.Ala216Thr	missense_variant					
-	KMT2C(2.8%)	exon38,c.8390dup,p.E2798fs	0.028	0.03	10418|384	2110|80	0.04059	27557|1166	7	151874147	151874148	CT	CTT	multiallelic,normal_artifact,background	KMT2C	NM_170606.3	38	c.8390dup	p.Glu2798fs	frameshift_variant	Pathogenic		not_provided		
	KMT2C(1.9%)	exon14,c.2185_2189delinsGATTA,p.N729_S730>DY	0.019	0.065	507|8	46|2	0.01134	523|6	7	151945330	151945334	GAATT	TAATC	haplotype,normal_artifact,strand_bias	KMT2C	NM_170606.3	14	c.2185_2189delinsGATTA	p.Asn729_Ser730delinsAspTyr	missense_variant					
-	KMT2C(0.8%)	exon8,c.1149G>A,p.W383*	0.008472	0.016	714|5	82|0	0.00654	912|6	7	151962158	151962158	C	T	PASS	KMT2C	NM_170606.3	8	c.1149G>A	p.Trp383*	stop_gained					
	PRKDC(1.1%)	exon74,c.10418G>A,p.R3473Q	0.011	0.014	583|7	89|0	0.01214	651|8	8	48710835	48710835	C	T	PASS	PRKDC	NM_006904.7	74	c.10418G>A	p.Arg3473Gln	missense_variant	Conflicting_classifications_of_pathogenicity	Uncertain_significance(1)|Likely_benign(1)	Severe_combined_immunodeficiency_due_to_DNA-PKcs_deficiency|not_specified		
	PRKDC(7.9%)	exon5,c.496del,p.I166fs	0.079	0.063	130|9	18|0	0.06977	160|12	8	48866909	48866910	AT	A	slippage,suspected_bg	PRKDC	NM_006904.7	5	c.496del	p.Ile166fs	frameshift_variant					
	NBN(0.4%)	exon11,c.1651del,p.R551fs	0.003718	0.004935	14415|118	3277|24	0.00673	45454|308	8	90965665	90965666	CT	C	normal_artifact,low_allele_frac	NBN	NM_002485.5	11	c.1651del	p.Arg551fs	frameshift_variant	Pathogenic/Likely_pathogenic		Aplastic_anemia|Hereditary_cancer-predisposing_syndrome		
	MYC(4.4%)	exon2,c.406G>A,p.D136N	0.044	0.067	120|4	15|0	0.03150	123|4	8	128750869	128750869	G	A	orientation	MYC	NM_002467.6	2	c.406G>A	p.Asp136Asn	missense_variant					
2	JAK2(1.2%)	exon21,c.2762-2A>G	0.012	0.013	409|5	98|0	0.01006	492|5	9	5090444	5090444	A	G	PASS	JAK2	NM_004972.4	21	c.2762-2A>G		splice_acceptor_variant&intron_variant					
	JAK2(0.8%)	exon21,c.2840G>A,p.R947Q	0.008028	0.01	737|6	119|0	0.00673	885|6	9	5090524	5090524	G	A	PASS	JAK2	NM_004972.4	21	c.2840G>A	p.Arg947Gln	missense_variant				COSV67673320	
	ABL1(2.5%)	exon11,c.1826_1828del,p.K609del	0.025	0.009509	985|26	116|0	0.01996	1522|31	9	133759489	133759492	CAAG	C	slippage,suspected_bg	ABL1	NM_005157.6	11	c.1826_1828del	p.Lys609del	disruptive_inframe_deletion					
-	TSC1(17.0%)	exon21,c.2626-5_2626-4del	0.17	0.099	18|15	0|0	0.16934	363|74	9	135773000	135773004	GAAAA	GAA	germline,multiallelic,normal_artifact	TSC1	NM_000368.5	21	c.2626-5_2626-4del		splice_region_variant&intron_variant	Benign		not_provided|not_specified|Tuberous_sclerosis_1|Lymphangiomyomatosis|Hereditary_cancer-predisposing_syndrome|Isolated_focal_cortical_dysplasia_type_II|Tuberous_sclerosis_syndrome		
-	TSC1(14.6%)	exon21,c.2626-3C>A	0.146	0.068	18|24	0|1	0.12319	363|51	9	135773000	135773000	G	T	germline,multiallelic,normal_artifact,suspected_bg	TSC1	NM_000368.5	21	c.2626-3C>A		splice_region_variant&intron_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome		
-	TSC1(1.0%)	exon12,c.1263+4C>T	0.00969	0.006812	1242|13	169|0	0.00997	1688|17	9	135785954	135785954	G	A	background	TSC1	NM_000368.5	12	c.1263+4C>T		splice_region_variant&intron_variant	Uncertain_significance		Tuberous_sclerosis_syndrome|Tuberous_sclerosis_1|Hereditary_cancer-predisposing_syndrome|not_provided		
	NOTCH1(44.4%)	exon5,c.852G>A,p.P284=	0.444	0.333	6|5	1|0	0.41667	7|5	9	139413908	139413908	C	T	germline	NOTCH1	NM_017617.5	5	c.852G>A	p.Pro284=	synonymous_variant	Benign		Familial_thoracic_aortic_aneurysm_and_aortic_dissection|Adams-Oliver_syndrome_5|Aortic_valve_disease_1|not_specified		
	TFAM(9.0%)	exon4,c.441del,p.E148fs	0.09	0.071	2881|345	554|45	0.08480	5267|488	10	60148569	60148570	CA	C	multiallelic,normal_artifact,slippage,background	TFAM	NM_003201.3	4	c.441del	p.Glu148fs	frameshift_variant&splice_region_variant	Likely_pathogenic		Mitochondrial_DNA_depletion_syndrome_15_(hepatocerebral_type)		
-	PTEN(4.7%)	exon8,c.802-4_802-3del	0.047	0.037	136|16	35|3	0.03120	621|20	10	89720633	89720635	CTT	C	germline,multiallelic,normal_artifact,suspected_bg	PTEN	NM_000314.8	8	c.802-4_802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		Breast_and/or_ovarian_cancer|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided		
-	PTEN(15.4%)	exon8,c.802-3del	0.154	0.138	136|63	35|9	0.16867	621|126	10	89720633	89720635	CTT	CT	germline,multiallelic,normal_artifact,Germline	PTEN	NM_000314.8	8	c.802-3del		splice_region_variant&intron_variant	Benign/Likely_benign		not_provided|PTEN_hamartoma_tumor_syndrome|Breast_and/or_ovarian_cancer|not_specified|Hereditary_cancer-predisposing_syndrome		
	IFITM3(3.9%)	exon1,c.208C>A,p.P70T	0.039	0.021	317|15	57|0	0.06338	399|27	11	320606	320606	G	T	background	IFITM3	NM_021034.3	1	c.208C>A	p.Pro70Thr	missense_variant				COSV67706711	
	IFITM3(4.1%)	exon1,c.165C>T,p.P55=	0.041	0.025	304|15	48|0	0.06500	374|26	11	320649	320649	G	A	background	IFITM3	NM_021034.3	1	c.165C>T	p.Pro55=	synonymous_variant				COSV67706701	
	ESRRA(12.0%)	exon7,c.1124_1127delinsAGCT,p.R375_R376>QL	0.12	0.088	258|35	34|2	0.13354	279|43	11	64083290	64083293	GGCG	AGCT	haplotype,normal_artifact	ESRRA	NM_004451.5	7	c.1124_1127delinsAGCT	p.Arg375_Arg376delinsGlnLeu	missense_variant					
	ESRRA(14.8%)	exon7,c.1152_1154delinsACC,p.L385P	0.148	0.1	205|43	28|2	0.21786	219|61	11	64083318	64083320	GCT	ACC	haplotype,normal_artifact	ESRRA	NM_004451.5	7	c.1152_1154delinsACC	p.Leu385Pro	missense_variant					
	ESRRA(15.3%)	exon7,c.1162_1165delinsTTCT,p.L388_R389>FC	0.153	0.103	201|43	27|3	0.21978	213|60	11	64083328	64083331	CTCC	TTCT	haplotype,normal_artifact	ESRRA	NM_004451.5	7	c.1162_1165delinsTTCT	p.Leu388_Arg389delinsPheCys	missense_variant					
	GSTP1(0.8%)	exon6,c.387T>C,p.P129=	0.007807	0.005759	1639|13	199|0	0.00698	2133|15	11	67353625	67353625	T	C	background,low_allele_frac,chemotherapy_site	GSTP1	NM_000852.4	6	c.387T>C	p.Pro129=	synonymous_variant					
	MRE11(1.4%)	exon10,c.1090C>T,p.R364*	0.014	0.024	380|6	46|0	0.01389	426|6	11	94200987	94200987	G	A	orientation	MRE11	NM_005591.4	10	c.1090C>T	p.Arg364*	stop_gained	Pathogenic		Hereditary_cancer-predisposing_syndrome|not_provided|Ataxia-telangiectasia-like_disorder_1|Ataxia-telangiectasia-like_disorder|Hereditary_breast_ovarian_cancer_syndrome		
	ATM(9.3%)	exon5,c.390T>A,p.D130E	0.093	0.012	507|49	102|0	0.09120	568|57	11	108106455	108106455	T	A	PASS	ATM	NM_000051.4	5	c.390T>A	p.Asp130Glu	missense_variant	Uncertain_significance		not_provided|Hereditary_cancer-predisposing_syndrome|Ataxia-telangiectasia_syndrome		
-	ATM(3.6%)	exon6,c.497-5_497-4del	0.036	0.068	187|10	30|3	0.03093	470|15	11	108114661	108114663	ATT	A	multiallelic,normal_artifact	ATM	NM_000051.4	6	c.497-5_497-4del		splice_region_variant&intron_variant	Likely_benign		not_specified|Hereditary_cancer-predisposing_syndrome		
-	ATM(7.7%)	exon6,c.497-4dup	0.077	0.086	187|26	30|4	0.11820	470|63	11	108114661	108114663	ATT	ATTT	multiallelic,normal_artifact,suspected_bg	ATM	NM_000051.4	6	c.497-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Ataxia-telangiectasia_syndrome		
-	ATM(10.0%)	exon10,c.1236-4_1236-3del	0.1	0.074	133|35	23|3	0.09240	442|45	11	108121410	108121412	CTT	C	germline,multiallelic,normal_artifact	ATM	NM_000051.4	10	c.1236-4_1236-3del		splice_region_variant&intron_variant	Benign		Hereditary_cancer-predisposing_syndrome|not_specified|not_provided|Breast_and/or_ovarian_cancer		
-	ATM(5.6%)	exon10,c.1236-3dup	0.056	0.074	133|18	23|4	0.08489	442|41	11	108121410	108121412	CTT	CTTT	germline,multiallelic,normal_artifact,suspected_bg	ATM	NM_000051.4	10	c.1236-3dup		splice_acceptor_variant&intron_variant	Benign/Likely_benign		not_provided|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_neoplasm|Breast_and/or_ovarian_cancer		
	ATM(1.5%)	exon53,c.7904C>T,p.A2635V	0.015	0.019	349|6	61|0	0.01429	414|6	11	108203604	108203604	C	T	PASS	ATM	NM_000051.4	53	c.7904C>T	p.Ala2635Val	missense_variant	Uncertain_significance		Hereditary_cancer-predisposing_syndrome		
	CEP164(5.6%)	exon5,c.347dup,p.E117fs	0.056	0.082	188|15	20|1	0.08442	282|26	11	117222647	117222648	GA	GAA	multiallelic,normal_artifact,slippage,suspected_bg	CEP164	NM_014956.5	5	c.347dup	p.Glu117fs	frameshift_variant	Conflicting_classifications_of_pathogenicity	Likely_pathogenic(1)|Benign(1)	Nephronophthisis_15		
	CD3G(4.6%)	exon3,c.213del,p.K71fs	0.046	0.046	3287|181	481|25	0.04615	5209|252	11	118220582	118220583	TA	T	multiallelic,normal_artifact,slippage,background	CD3G	NM_000073.3	3	c.213del	p.Lys71fs	frameshift_variant	Pathogenic/Likely_pathogenic		Severe_combined_immunodeficiency_disease|Combined_immunodeficiency_due_to_CD3gamma_deficiency		
	CD3G(1.3%)	exon3,c.213dup,p.W72fs	0.013	0.019	3287|65	481|11	0.02031	5209|108	11	118220582	118220583	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	CD3G	NM_000073.3	3	c.213dup	p.Trp72fs	frameshift_variant	Pathogenic/Likely_pathogenic		Combined_immunodeficiency_due_to_CD3gamma_deficiency|Severe_combined_immunodeficiency_disease		
	CHD4(10.4%)	exon18,c.2693T>G,p.L898R	0.104	0.002113	3110|383	582|2	0.10468	4516|528	12	6701943	6701943	A	C	PASS	CHD4	NM_001273.5	18	c.2693T>G	p.Leu898Arg	missense_variant					
1	KRAS(0.3%)	exon4,c.437C>T,p.A146V	0.002702	0.001283	11276|34	2913|3	0.00268	37641|101	12	25378561	25378561	G	A	PASS	KRAS	NM_033360.4	4	c.437C>T	p.Ala146Val	missense_variant	Conflicting_classifications_of_pathogenicity	Pathogenic(1)|Uncertain_significance(1)	Thyroid_tumor|Neoplasm_of_the_large_intestine|Encephalocraniocutaneous_lipomatosis|OCULOECTODERMAL_SYNDROME,_SOMATIC|not_provided|RASopathy|Malignant_tumor_of_urinary_bladder|Non-small_cell_lung_carcinoma		
1	KRAS(0.1%)	exon4,c.436G>C,p.A146P	0.001312	0.0009284	11364|15	2919|2	0.00084	38023|32	12	25378562	25378562	C	G	PASS	KRAS	NM_033360.4	4	c.436G>C	p.Ala146Pro	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|RASopathy|Multiple_myeloma|Autoimmune_lymphoproliferative_syndrome_type_4		
1	KRAS(0.1%)	exon3,c.175G>A,p.A59T	0.0009119	0.001625	9118|10	2048|3	0.00158	24633|39	12	25380283	25380283	C	T	strand_bias,weak_evidence	KRAS	NM_033360.4	3	c.175G>A	p.Ala59Thr	missense_variant	Pathogenic/Likely_pathogenic		Neoplasm_of_the_large_intestine|Bladder_cancer,_transitional_cell,_somatic		
	KMT2D(66.4%)	exon40,c.12510A>G,p.P4170=	0.664	0.167	7|15	6|0	0.66667	7|14	12	49425978	49425978	T	C	germline	KMT2D	NM_003482.4	40	c.12510A>G	p.Pro4170=	synonymous_variant	Benign		Kabuki_syndrome_1|not_specified|Kabuki_syndrome|not_provided		
	KMT2D(59.7%)	exon40,c.10836G>A,p.Q3612=	0.597	0.586	12|18	1|2	0.62162	14|23	12	49427652	49427652	C	T	germline,normal_artifact,Germline	KMT2D	NM_003482.4	40	c.10836G>A	p.Gln3612=	synonymous_variant	Benign		Kabuki_syndrome_1|not_provided|not_specified|Kabuki_syndrome		
	KMT2D(0.3%)	exon11,c.1367_1420del,p.S456_E473del	0.003251	0.005263	2264|7	222|0	0.00317	944|3	12	49446045	49446099	AATTCCTCAGGTGGTGGTGACAGGCGTGATGCCTCAGGTGGTGGGGACGTGGGTG	A	low_allele_frac	KMT2D	NM_003482.4	11	c.1367_1420del	p.Ser456_Glu473del	disruptive_inframe_deletion					
	SCYL2(2.1%)	exon17,c.2104C>G,p.L702V	0.021	0.003056	1980|40	398|0	0.01774	2935|53	12	100731243	100731243	C	G	PASS	SCYL2	NM_017988.6	17	c.2104C>G	p.Leu702Val	missense_variant				COSV105918226	
-	HNF1A(4.2%)	exon4,c.872del,p.P291fs	0.042	0.032	158|9	32|0	0.04128	209|9	12	121432117	121432118	GC	G	slippage,weak_evidence,background	HNF1A	NM_000545.8	4	c.872del	p.Pro291fs	frameshift_variant	Pathogenic		not_provided|Monogenic_diabetes|Maturity-onset_diabetes_of_the_young_type_3		
	POLE(40.0%)	exon35,c.4530A>G,p.A1510=	0.4	0.594	35|21	2|3	0.33871	41|21	12	133219831	133219831	T	C	germline,normal_artifact,Germline	POLE	NM_006231.4	35	c.4530A>G	p.Ala1510=	synonymous_variant	Benign		not_specified|Intrauterine_growth_retardation,_metaphyseal_dysplasia,_adrenal_hypoplasia_congenita,_genital_anomalies,_and_immunodeficiency|Hereditary_cancer-predisposing_syndrome|Facial_dysmorphism-immunodeficiency-livedo-short_stature_syndrome|Colorectal_cancer,_susceptibility_to,_12|not_provided		
	POLE(5.3%)	exon34,c.4337_4338del,p.V1446fs	0.053	0.062	134|7	14|0	0.04678	163|8	12	133220098	133220100	CCA	C	slippage,distinguished	POLE	NM_006231.4	34	c.4337_4338del	p.Val1446fs	frameshift_variant	Conflicting_classifications_of_pathogenicity	Pathogenic(1)|Uncertain_significance(1)	Hereditary_cancer-predisposing_syndrome|not_provided		
-	BRCA2(1.9%)	exon10,c.1813del,p.I605fs	0.019	0.023	3516|88	557|15	0.01986	6466|131	13	32907420	32907421	GA	G	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	10	c.1813del	p.Ile605fs	frameshift_variant	Pathogenic		Gastric_cancer|not_provided|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|Hereditary_breast_ovarian_cancer_syndrome|Fanconi_anemia_complementation_group_D1|Breast-ovarian_cancer,_familial,_susceptibility_to,_2		
-	BRCA2(0.7%)	exon10,c.1813dup,p.I605fs	0.007039	0.008626	3516|40	557|9	0.00980	6466|64	13	32907420	32907421	GA	GAA	clustered_events,multiallelic,normal_artifact,slippage,suspected_bg,low_allele_frac	BRCA2	NM_000059.4	10	c.1813dup	p.Ile605fs	frameshift_variant	Pathogenic		Hereditary_cancer-predisposing_syndrome|BRCA2-related_disorder|Breast_and/or_ovarian_cancer|Hereditary_breast_ovarian_cancer_syndrome|Familial_cancer_of_breast|Fanconi_anemia_complementation_group_D1|Carcinoma_of_pancreas|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Breast_carcinoma|not_provided		
-	BRCA2(2.3%)	exon23,c.9097dup,p.T3033fs	0.023	0.022	3216|82	666|17	0.02336	5435|130	13	32954022	32954022	C	CA	normal_artifact,slippage,suspected_bg	BRCA2	NM_000059.4	23	c.9097dup	p.Thr3033fs	frameshift_variant	Pathogenic		Gastric_cancer|Malignant_lymphoma,_large_B-cell,_diffuse|Hereditary_cancer-predisposing_syndrome|Neoplasm_of_ovary|Familial_cancer_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_2|Hereditary_breast_ovarian_cancer_syndrome|See_cases|not_provided|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Breast_carcinoma|Breast_and/or_ovarian_cancer		
	NBEA(0.8%)	exon22,c.3362del,p.N1121fs	0.008302	0.017	5879|82	1063|22	0.01112	10759|121	13	35733662	35733663	TA	T	multiallelic,normal_artifact,slippage,suspected_bg	NBEA	NM_015678.5	22	c.3362del	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy		
	NBEA(0.9%)	exon22,c.3362dup,p.N1121fs	0.008756	0.006537	5879|77	1063|8	0.01030	10759|112	13	35733662	35733663	TA	TAA	multiallelic,normal_artifact,slippage,suspected_bg	NBEA	NM_015678.5	22	c.3362dup	p.Asn1121fs	frameshift_variant	Likely_pathogenic		Neurodevelopmental_disorder_with_or_without_early-onset_generalized_epilepsy		
-	RB1(3.3%)	exon7,c.608-4del	0.033	0.039	8978|368	2072|100	0.03269	30773|1040	13	48934140	48934141	AT	A	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	7	c.608-4del		splice_region_variant&intron_variant	Benign/Likely_benign		not_provided|RB1-related_disorder|Retinoblastoma|Hereditary_cancer-predisposing_syndrome|not_specified		
-	RB1(2.3%)	exon7,c.608-4dup	0.023	0.024	8978|283	2072|63	0.03378	30773|1076	13	48934140	48934141	AT	ATT	multiallelic,normal_artifact,slippage,suspected_bg	RB1	NM_000321.3	7	c.608-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Retinoblastoma|RB1-related_disorder		
-	RB1(0.3%)	exon7,c.608-3C>T	0.002546	0.002942	10419|34	2443|5	0.00346	36030|125	13	48934150	48934150	C	T	normal_artifact,low_allele_frac	RB1	NM_000321.3	7	c.608-3C>T		splice_region_variant&intron_variant					
	IRS2(50.1%)	exon1,c.2673G>C,p.T891=	0.501	0.75	4|5	0|2	0.50000	5|5	13	110435728	110435728	C	G	germline,normal_artifact	IRS2	NM_003749.3	1	c.2673G>C	p.Thr891=	synonymous_variant				COSV65478983	
	IRS2(85.7%)	exon1,c.2448T>C,p.C816=	0.857	0.5	0|6	0|0	1.00000	0|6	13	110435953	110435953	A	G	germline	IRS2	NM_003749.3	1	c.2448T>C	p.Cys816=	synonymous_variant	Benign		IRS2-related_disorder		
	IRS2(85.7%)	exon1,c.2169C>T,p.S723=	0.857	0.743	0|6	0|2	1.00000	0|6	13	110436232	110436232	G	A	germline,normal_artifact	IRS2	NM_003749.3	1	c.2169C>T	p.Ser723=	synonymous_variant	Benign		IRS2-related_disorder		
	BCL2L2(50.4%)	exon3,c.123G>A,p.P41=	0.504	0.224	47|46	8|2	0.48624	56|53	14	23777099	23777099	G	A	germline,normal_artifact,Germline	BCL2L2	NM_004050.5	3	c.123G>A	p.Pro41=	synonymous_variant				COSV51635377	
	DDHD1(94.4%)	exon1,c.273C>T,p.F91=	0.944	0.75	0|24	0|3	1.00000	0|24	14	53619544	53619544	G	A	germline,normal_artifact,Germline	DDHD1	NM_001160148.2	1	c.273C>T	p.Phe91=	synonymous_variant	Benign		Hereditary_spastic_paraplegia_28|not_specified		
	PHGR1(16.4%)	exon4,c.135_200del,p.P46_P67del	0.164	0.043	284|9	65|0	0.16232	289|56	15	40648314	40648380	ACTGCGGGCCACCCCCTGGCCATGGCCCAGGGCCCTGCGGGCCACCCCCCCACCATGGTCCAGGGCC	A	slippage	PHGR1	NM_001145643.2	4	c.135_200del	p.Pro46_Pro67del	disruptive_inframe_deletion					
	GOLGA6L4(62.3%)	exon6,c.1279G>A,p.D427N	0.623	0.333	8|14	2|0	0.65385	9|17	15	84909385	84909385	G	A	germline,Germline	GOLGA6L4	NM_001267536.3	6	c.1279G>A	p.Asp427Asn	missense_variant				COSV65606843	
	NTRK3(41.8%)	exon7,c.573C>T,p.N191=	0.418	0.338	43|26	8|3	0.38750	49|31	15	88680684	88680684	G	A	germline,normal_artifact,Germline	NTRK3	NM_001012338.3	7	c.573C>T	p.Asn191=	synonymous_variant	Benign		not_provided		
	BLM(2.4%)	exon7,c.1544del,p.N515fs	0.024	0.027	12865|389	2771|104	0.02763	43224|1228	15	91304138	91304139	GA	G	multiallelic,normal_artifact,slippage,suspected_bg	BLM	NM_000057.4	7	c.1544del	p.Asn515fs	frameshift_variant	Pathogenic		not_provided|Bloom_syndrome|Hereditary_cancer-predisposing_syndrome|BLM-related_condition		
	BLM(1.5%)	exon7,c.1544dup,p.N515fs	0.015	0.029	12865|283	2771|103	0.02806	43224|1248	15	91304138	91304139	GA	GAA	multiallelic,normal_artifact,slippage,background	BLM	NM_000057.4	7	c.1544dup	p.Asn515fs	frameshift_variant	Pathogenic/Likely_pathogenic		Hereditary_cancer-predisposing_syndrome|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Bloom_syndrome		
	CHD2(1.9%)	exon2,c.22A>G,p.S8G	0.019	0.02	356|6	56|0	0.01636	421|7	15	93444489	93444489	A	G	distinguished	CHD2	NM_001271.4	2	c.22A>G	p.Ser8Gly	missense_variant					
	CHD2(5.9%)	exon29,c.3734del,p.K1245fs	0.059	0.037	1194|95	205|8	0.05839	1677|104	15	93540315	93540317	GAA	GA	multiallelic,normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734del	p.Lys1245fs	frameshift_variant&splice_region_variant	Conflicting_classifications_of_pathogenicity	Pathogenic(4)|Uncertain_significance(1)|Benign(1)	History_of_neurodevelopmental_disorder|Developmental_and_epileptic_encephalopathy_94|not_provided|not_specified		
	CHD2(3.9%)	exon29,c.3734dup	0.039	0.077	1194|70	205|18	0.05093	1677|90	15	93540315	93540317	GAA	GAAA	multiallelic,normal_artifact,slippage,suspected_bg	CHD2	NM_001271.4	29	c.3734dup		splice_donor_variant&intron_variant	Pathogenic/Likely_pathogenic		CHD2-related_disorder|Developmental_and_epileptic_encephalopathy_94		
	CHD2(2.1%)	exon33,c.4173dup,p.Q1392fs	0.021	0.066	451|11	57|3	0.02451	597|15	15	93545433	93545433	G	GA	normal_artifact,slippage,weak_evidence,suspected_bg	CHD2	NM_001271.4	33	c.4173dup	p.Gln1392fs	frameshift_variant	Pathogenic		Complex_neurodevelopmental_disorder|Autistic_behavior|Seizure|Developmental_and_epileptic_encephalopathy_94|not_provided|CHD2-related_disorder		
	SLX4(2.7%)	exon2,c.201C>G,p.I67M	0.027	0.026	438|10	52|0	0.01957	501|10	16	3658765	3658765	G	C	PASS	SLX4	NM_032444.4	2	c.201C>G	p.Ile67Met	missense_variant					
	GRIN2A(1.2%)	exon5,c.1288G>A,p.V430M	0.012	0.015	477|5	81|0	0.00917	540|5	16	9943653	9943653	C	T	PASS	GRIN2A	NM_001134407.3	5	c.1288G>A	p.Val430Met	missense_variant	Uncertain_significance		Inborn_genetic_diseases		
	PALB2(1.0%)	exon4,c.886del,p.M296*	0.009767	0.012	4841|55	1211|15	0.01101	10601|118	16	23646980	23646981	AT	A	normal_artifact,suspected_bg	PALB2	NM_024675.4	4	c.886del	p.Met296*	frameshift_variant&stop_gained	Pathogenic		Familial_cancer_of_breast|not_provided|Hereditary_cancer-predisposing_syndrome		
	PRSS8(0.5%)	exon5,c.689G>A,p.G230D	0.004776	0.003601	2197|12	300|0	0.00339	4709|16	16	31143766	31143766	C	T	background,low_allele_frac	PRSS8	NM_002773.5	5	c.689G>A	p.Gly230Asp	missense_variant					
	PRSS8(0.3%)	exon5,c.642G>A,p.P214=	0.00265	0.004226	4333|13	548|1	0.00291	8579|25	16	31143813	31143813	C	T	background,low_allele_frac	PRSS8	NM_002773.5	5	c.642G>A	p.Pro214=	synonymous_variant				COSV54898066	
-	CYLD(1.2%)	exon16,c.2165del,p.N722fs	0.012	0.005771	1256|23	217|2	0.01529	1610|25	16	50825518	50825519	GA	G	suspected_bg	CYLD	NM_015247.3	16	c.2165del	p.Asn722fs	frameshift_variant					
	CTCF(8.8%)	exon7,c.1243C>T,p.R415W	0.088	0.003934	1791|171	346|0	0.08739	2402|230	16	67655380	67655380	C	T	PASS	CTCF	NM_006565.4	7	c.1243C>T	p.Arg415Trp	missense_variant				COSV50464143	
-	CDH1(0.5%)	exon3,c.259del,p.R87fs	0.005031	0.004335	12084|82	2622|12	0.00504	33951|172	16	68835664	68835665	CA	C	clustered_events,normal_artifact,low_allele_frac	CDH1	NM_004360.5	3	c.259del	p.Arg87fs	frameshift_variant	Pathogenic		CDH1-related_diffuse_gastric_and_lobular_breast_cancer_syndrome|Hereditary_cancer-predisposing_syndrome|Hereditary_diffuse_gastric_adenocarcinoma		
	CDH1(0.9%)	exon8,c.1068C>T,p.S356=	0.009053	0.012	858|8	109|0	0.00748	1061|8	16	68846097	68846097	C	T	PASS	CDH1	NM_004360.5	8	c.1068C>T	p.Ser356=	synonymous_variant					
	NQO1(0.5%)	exon6,c.524G>A,p.G175D	0.00513	0.00197	8253|46	1626|2	0.00513	16880|87	16	69745180	69745180	C	T	low_allele_frac,chemotherapy_site	NQO1	NM_000903.3	6	c.524G>A	p.Gly175Asp	missense_variant					
	PKD1L2(0.5%)	exon4,c.741G>A,p.V247=	0.004553	0.003914	1919|9	363|0	0.00389	2562|10	16	81242115	81242115	C	T	low_allele_frac	PKD1L2	NM_001076780.2	4	c.741G>A	p.Val247=	synonymous_variant					
	FANCA(1.6%)	exon18,c.1676A>G,p.E559G	0.016	0.034	272|4	33|0	0.01286	307|4	16	89846316	89846316	T	C	PASS	FANCA	NM_000135.4	18	c.1676A>G	p.Glu559Gly	missense_variant	Uncertain_significance		Fanconi_anemia|Fanconi_anemia_complementation_group_A		
	TP53(17.5%)	exon7,c.743G>A,p.R248Q	0.175	0.00434	1900|395	304|0	0.17829	2581|560	17	7577538	7577538	C	T	distinguished	TP53	NM_000546.6	7	c.743G>A	p.Arg248Gln	missense_variant	Pathogenic		Uterine_carcinosarcoma|Prostate_adenocarcinoma|Malignant_neoplasm_of_body_of_uterus|Neoplasm_of_the_large_intestine|Myelodysplastic_syndrome|Glioblastoma|Colorectal_cancer|Carcinoma_of_esophagus|Multiple_myeloma|Small_cell_lung_carcinoma|Hereditary_cancer-predisposing_syndrome|Li-Fraumeni_syndrome_1|Squamous_cell_lung_carcinoma|Sarcoma|Rhabdomyosarcoma|Pancreatic_adenocarcinoma|Bone_osteosarcoma|Nasopharyngeal_carcinoma|Glioma_susceptibility_1|Familial_cancer_of_breast|Hepatocellular_carcinoma|Carcinoma_of_colon|Carcinoma_of_pancreas|Choroid_plexus_papilloma|Basal_cell_carcinoma,_susceptibility_to,_7|Adrenocortical_carcinoma,_hereditary|not_provided|Medulloblastoma|Ovarian_serous_cystadenocarcinoma|Gastric_adenocarcinoma|Adrenal_cortex_carcinoma|Breast_carcinoma|B-cell_chronic_lymphocytic_leukemia|Lip_and_oral_cavity_carcinoma|Neoplasm|Ductal_carcinoma_in_situ|Neoplasm_of_ovary|Lung_adenocarcinoma|Lymphoma|Gastric_cancer|Breast_neoplasm|Li-Fraumeni_syndrome|Squamous_cell_carcinoma_of_the_skin|Acute_myeloid_leukemia|Brainstem_glioma|Transitional_cell_carcinoma_of_the_bladder|Neoplasm_of_brain|Squamous_cell_carcinoma_of_the_head_and_neck|Malignant_melanoma_of_skin|Malignant_tumor_of_urinary_bladder		
	MAP2K4(1.1%)	exon2,c.146C>T,p.A49V	0.011	0.019	1104|10	217|2	0.00802	1361|11	17	11958236	11958236	C	T	normal_artifact	MAP2K4	NM_003010.4	2	c.146C>T	p.Ala49Val	missense_variant					
	LGALS9B(87.5%)	exon1,c.17C>G,p.S6C	0.875	0.5	0|6	0|0	1.00000	0|8	17	20370767	20370767	G	C	germline,Germline	LGALS9B	NM_001042685.3	1	c.17C>G	p.Ser6Cys	missense_variant	Benign		not_specified		
-	NF1(2.2%)	exon2,c.61-4del	0.022	0.036	1116|32	194|8	0.02539	1689|44	17	29482988	29482989	CT	C	multiallelic,normal_artifact,slippage,suspected_bg	NF1	NM_000267.3	2	c.61-4del		splice_region_variant&intron_variant	Benign/Likely_benign		Hereditary_cancer-predisposing_syndrome|Cardiovascular_phenotype|Neurofibromatosis-Noonan_syndrome|not_provided|Caf??-au-lait_macules_with_pulmonary_stenosis|Neurofibromatosis,_familial_spinal|Neurofibromatosis,_type_1|not_specified		
-	NF1(1.9%)	exon2,c.61-4dup	0.019	0.00654	1116|36	194|1	0.03154	1689|55	17	29482988	29482989	CT	CTT	multiallelic,normal_artifact,slippage,suspected_bg	NF1	NM_000267.3	2	c.61-4dup		splice_region_variant&intron_variant	Benign/Likely_benign		Neurofibromatosis,_type_1|not_provided|Hereditary_cancer-predisposing_syndrome		
	CDK12(1.8%)	exon5,c.2272G>A,p.V758M	0.018	0.059	259|4	18|0	0.01333	296|4	17	37650800	37650800	G	A	PASS	CDK12	NM_016507.4	5	c.2272G>A	p.Val758Met	missense_variant					
	CDK12(5.6%)	exon14,c.4382del,p.G1461fs	0.056	0.053	87|5	17|0	0.04000	120|5	17	37687471	37687472	TG	T	distinguished	CDK12	NM_016507.4	14	c.4382del	p.Gly1461fs	frameshift_variant					
	ERBB2(0.3%)	exon7,c.798G>A,p.L266=	0.003047	0.002942	3764|15	693|1	0.00352	6798|24	17	37866631	37866631	G	A	low_allele_frac	ERBB2	NM_004448.4	7	c.798G>A	p.Leu266=	synonymous_variant				COSV54062307	
	ERBB2(1.5%)	exon15,c.1741G>A,p.A581T	0.015	0.024	401|5	41|0	0.00943	630|6	17	37873576	37873576	G	A	PASS	ERBB2	NM_004448.4	15	c.1741G>A	p.Ala581Thr	missense_variant					
	KRTAP4-7(4.6%)	exon1,c.169T>C,p.S57P	0.046	0.022	472|34	59|0	0.06642	759|54	17	39240627	39240627	T	C	background	KRTAP4-7	NM_033061.3	1	c.169T>C	p.Ser57Pro	missense_variant				COSV66950945	
	KRTAP4-7(6.4%)	exon1,c.321C>A,p.P107=	0.064	0.041	182|12	33|0	0.08251	278|25	17	39240779	39240779	C	A	haplotype,background	KRTAP4-7	NM_033061.3	1	c.321C>A	p.Pro107=	synonymous_variant				COSV66951092	
	KRTAP4-11(5.6%)	exon1,c.109_221delinsTCCACCTA,p.T37_C74>STY	0.056	0.073	316|21	29|1	0.00000	10|0	17	39274347	39274459	CAGCTGGAGATGCAGCATCTGGGGCGGCAGCAGGTGGGCTGGCAGCACACAGACTGGCAGCACTGGGGCCTGCAGCAGCTGGACACACAGCAGCTGGGGCGACAGTAGGTGGT	TAGGTGGA	haplotype,normal_artifact	KRTAP4-11	NM_033059.4	1	c.109_221delinsTCCACCTA	p.Thr37_Cys74delinsSerThrTyr	missense_variant&conservative_inframe_deletion					
	KRTAP4-11(8.4%)	exon1,c.131_133delinsACA,p.C44_C45>YS	0.084	0.125	266|22	23|2	0.06600	467|33	17	39274435	39274437	AGC	TGT	haplotype,normal_artifact	KRTAP4-11	NM_033059.4	1	c.131_133delinsACA	p.Cys44_Cys45delinsTyrSer	missense_variant					
	KRTAP4-11(7.2%)	exon1,c.116_120delinsGCTAC,p.Y39_C40>CY	0.072	0.091	259|18	22|1	0.04835	374|19	17	39274448	39274452	ACAGT	GTAGC	haplotype,normal_artifact	KRTAP4-11	NM_033059.4	1	c.116_120delinsGCTAC	p.Tyr39_Cys40delinsCysTyr	missense_variant					
-	BRCA1(0.7%)	exon10,c.1961del,p.K654fs	0.007303	0.009632	2065|19	280|3	0.00761	2740|21	17	41245586	41245587	CT	C	slippage,suspected_bg,low_allele_frac	BRCA1	NM_007294.4	10	c.1961del	p.Lys654fs	frameshift_variant	Pathogenic		Familial_cancer_of_breast|Hereditary_cancer-predisposing_syndrome|Breast_neoplasm|Hereditary_breast_ovarian_cancer_syndrome|not_provided|Malignant_tumor_of_breast|Breast-ovarian_cancer,_familial,_susceptibility_to,_1|Fanconi_anemia,_complementation_group_S|Infiltrating_duct_carcinoma_of_breast		
	SPOP(2.0%)	exon6,c.552C>T,p.C184=	0.02	0.023	315|6	48|0	0.02105	372|8	17	47688748	47688748	G	A	background	SPOP	NM_001007228.2	6	c.552C>T	p.Cys184=	synonymous_variant				COSV100753299	
	XYLT2(1.1%)	exon8,c.1584del,p.G529fs	0.011	0.017	2595|48	449|7	0.01334	3845|52	17	48433966	48433967	AC	A	normal_artifact,suspected_bg	XYLT2	NM_022167.4	8	c.1584del	p.Gly529fs	frameshift_variant	Likely_pathogenic		Spondylo-ocular_syndrome		
-	RNF43(2.3%)	exon9,c.1976del,p.G659fs	0.023	0.015	622|12	86|1	0.01370	864|12	17	56435160	56435161	AC	A	suspected_bg	RNF43	NM_017763.6	9	c.1976del	p.Gly659fs	frameshift_variant	Likely_pathogenic		not_provided		
	BRIP1(1.7%)	exon15,c.2142G>A,p.W714*	0.017	0.02	496|7	65|0	0.01173	590|7	17	59821908	59821908	C	T	orientation,suspected_bg	BRIP1	NM_032043.3	15	c.2142G>A	p.Trp714*	stop_gained	Pathogenic		Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast		
	RPTOR(88.9%)	exon11,c.1269C>T,p.G423=	0.889	0.667	0|12	0|1	1.00000	0|14	17	78820329	78820329	C	T	germline,normal_artifact	RPTOR	NM_020761.3	11	c.1269C>T	p.Gly423=	synonymous_variant				COSV60802623	
	RPTOR(50.0%)	exon14,c.1518A>G,p.Q506=	0.5	0.333	6|6	1|0	0.50000	6|6	17	78854223	78854223	A	G	germline,Germline	RPTOR	NM_020761.3	14	c.1518A>G	p.Gln506=	synonymous_variant				COSV60803658	
	RPTOR(54.6%)	exon22,c.2526C>T,p.T842=	0.546	0.375	6|7	5|3	0.53846	6|7	17	78896529	78896529	C	T	germline,normal_artifact,Germline	RPTOR	NM_020761.3	22	c.2526C>T	p.Thr842=	synonymous_variant				COSV60802444	
	RPTOR(16.7%)	exon25,c.2948A>G,p.Q983R	0.167	0.2	34|7	4|0	0.15556	38|7	17	78914324	78914324	A	G	PASS	RPTOR	NM_020761.3	25	c.2948A>G	p.Gln983Arg	missense_variant					
	RPTOR(96.2%)	exon27,c.3231C>T,p.N1077=	0.962	0.75	0|32	0|3	1.00000	0|32	17	78921117	78921117	C	T	germline,haplotype,normal_artifact,Germline	RPTOR	NM_020761.3	27	c.3231C>T	p.Asn1077=	synonymous_variant				COSV60802469	
	TXNDC2(9.4%)	exon2,c.771_772insCTAGAGGAAGC,p.S258fs	0.094	0.131	119|7	25|2	0.09310	263|27	18	9887246	9887246	C	CCCTAGAGGAAG	haplotype,normal_artifact	TXNDC2	NM_001098529.2	2	c.771_772insCTAGAGGAAGC	p.Ser258fs	frameshift_variant					
	TXNDC2(6.2%)	exon2,c.976_980delinsAAGGA,p.E326_G327>KD	0.062	0.048	98|5	20|0	0.04800	357|18	18	9887452	9887456	GAGGG	AAGGA	PASS	TXNDC2	NM_001098529.2	2	c.976_980delinsAAGGA	p.Glu326_Gly327delinsLysAsp	missense_variant					
	BCL2(43.6%)	exon2,c.127G>A,p.A43T	0.436	0.471	9|6	1|1	0.35000	13|7	18	60985773	60985773	C	T	germline,normal_artifact	BCL2	NM_000633.3	2	c.127G>A	p.Ala43Thr	missense_variant				COSV61380124	
	KEAP1(2.5%)	exon3,c.1268G>A,p.G423D	0.025	0.023	290|6	49|0	0.01613	366|6	19	10602310	10602310	C	T	PASS	KEAP1	NM_203500.2	3	c.1268G>A	p.Gly423Asp	missense_variant					
	SMARCA4(47.1%)	exon9,c.1524T>C,p.H508=	0.471	0.396	36|38	3|2	0.52632	36|40	19	11105608	11105608	T	C	germline,normal_artifact,Germline	SMARCA4	NM_001128849.3	9	c.1524T>C	p.His508=	synonymous_variant	Benign		Rhabdoid_tumor_predisposition_syndrome_2|Coffin-Siris_syndrome|not_specified|Intellectual_disability,_autosomal_dominant_16|Hereditary_cancer-predisposing_syndrome		
	NOTCH3(81.8%)	exon25,c.4563A>G,p.P1521=	0.818	0.5	0|4	0|0	1.00000	0|4	19	15285052	15285052	T	C	germline	NOTCH3	NM_000435.3	25	c.4563A>G	p.Pro1521=	synonymous_variant	Benign		Lateral_meningocele_syndrome|Cerebral_arteriopathy,_autosomal_dominant,_with_subcortical_infarcts_and_leukoencephalopathy,_type_1|not_specified|not_provided		
	NOTCH3(80.0%)	exon4,c.606A>G,p.A202=	0.8	0.5	0|4	0|0	1.00000	0|4	19	15302844	15302844	T	C	germline	NOTCH3	NM_000435.3	4	c.606A>G	p.Ala202=	synonymous_variant	Benign		Lateral_meningocele_syndrome|not_provided|Cerebral_arteriopathy,_autosomal_dominant,_with_subcortical_infarcts_and_leukoencephalopathy,_type_1|not_specified		
	NOTCH3(38.9%)	exon3,c.303C>T,p.T101=	0.389	0.375	40|23	5|3	0.37500	45|27	19	15303225	15303225	G	A	germline,normal_artifact,Germline	NOTCH3	NM_000435.3	3	c.303C>T	p.Thr101=	synonymous_variant	Benign		not_specified|not_provided|Lateral_meningocele_syndrome|Cerebral_arteriopathy,_autosomal_dominant,_with_subcortical_infarcts_and_leukoencephalopathy,_type_1		
	BRD4(0.4%)	exon8,c.1424del,p.P475fs	0.004337	0.002384	3593|35	545|4	0.00424	6341|27	19	15367901	15367902	AG	A	low_allele_frac	BRD4	NM_058243.3	8	c.1424del	p.Pro475fs	frameshift_variant					
	BRD4(0.6%)	exon8,c.1420C>T,p.P474S	0.005632	0.00409	3755|25	568|1	0.00565	6682|38	19	15367906	15367906	G	A	background,low_allele_frac	BRD4	NM_058243.3	8	c.1420C>T	p.Pro474Ser	missense_variant					
	PIK3R2(94.6%)	exon8,c.937T>C,p.S313P	0.946	0.684	0|18	0|1	1.00000	0|18	19	18273047	18273047	T	C	germline,normal_artifact,Germline	PIK3R2	NM_005027.4	8	c.937T>C	p.Ser313Pro	missense_variant	Benign		not_specified|Megalencephaly-polymicrogyria-polydactyly-hydrocephalus_syndrome_1		
	AXL(94.7%)	exon7,c.796A>G,p.N266D	0.947	0.75	0|22	0|3	1.00000	0|41	19	41743861	41743861	A	G	germline,normal_artifact,Germline	AXL	NM_021913.5	7	c.796A>G	p.Asn266Asp	missense_variant	Benign		not_provided		
	XRCC1(1.8%)	exon10,c.1136G>A,p.R379H	0.018	0.027	491|11	40|0	0.01763	613|11	19	44055786	44055786	C	T	suspected_bg,chemotherapy_site	XRCC1	NM_006297.3	10	c.1136G>A	p.Arg379His	missense_variant				COSV53449842	
	BAX(2.5%)	exon3,c.121del,p.E41fs	0.025	0.032	2355|79	314|10	0.02607	3960|106	19	49458970	49458971	TG	T	multiallelic,normal_artifact,slippage,suspected_bg	BAX	NM_138761.4	3	c.121del	p.Glu41fs	frameshift_variant	Pathogenic		Carcinoma_of_colon		
	PPP2R1A(1.3%)	exon4,c.444C>T,p.C148=	0.013	0.017	527|7	74|0	0.01452	611|9	19	52714686	52714686	C	T	background	PPP2R1A	NM_014225.6	4	c.444C>T	p.Cys148=	synonymous_variant	Likely_benign		not_provided		
	DEFB126(0.2%)	exon2,c.262G>A,p.A88T	0.002479	0.001239	5455|16	933|0	0.00270	9602|26	20	126259	126259	G	A	low_allele_frac	DEFB126	NM_030931.4	2	c.262G>A	p.Ala88Thr	missense_variant				COSV66695088	
	SRC(92.8%)	exon12,c.1218G>C,p.A406=	0.928	0.5	0|20	0|0	1.00000	0|18	20	36030939	36030939	G	C	germline	SRC	NM_198291.3	12	c.1218G>C	p.Ala406=	synonymous_variant				COSV62440282	
	ADNP(2.1%)	exon5,c.3047dup,p.A1017fs	0.021	0.025	10333|277	1848|51	0.02460	25256|637	20	49508203	49508204	CT	CTT	clustered_events,multiallelic,normal_artifact,suspected_bg	ADNP	NM_015339.5	5	c.3047dup	p.Ala1017fs	frameshift_variant	Pathogenic/Likely_pathogenic		not_provided|ADNP-related_multiple_congenital_anomalies_-_intellectual_disability_-_autism_spectrum_disorder		
	CBR3(0.2%)	exon3,c.719G>A,p.S240N	0.001533	0.0009116	6463|10	1459|0	0.00134	12713|17	21	37518695	37518695	G	A	low_allele_frac,chemotherapy_site	CBR3	NM_001236.4	3	c.719G>A	p.Ser240Asn	missense_variant					
	U2AF1(0.1%)	exon2,c.120G>A,p.P40=	0.00137	0.0009339	7699|10	1324|0	0.00103	15548|16	21	44524437	44524437	C	T	strand_bias,low_allele_frac	U2AF1	NM_006758.3	2	c.120G>A	p.Pro40=	synonymous_variant				COSV52350234	
	GGT1(4.6%)	exon13,c.1283G>A,p.S428N	0.046	0.033	496|31	71|2	0.09145	616|62	22	25023893	25023893	G	A	haplotype,normal_artifact	GGT1	NM_001288833.2	13	c.1283G>A	p.Ser428Asn	missense_variant				COSV50637964	
	GGT1(5.0%)	exon13,c.1305A>G,p.V435=	0.05	0.037	402|30	56|2	0.11275	480|61	22	25023915	25023915	A	G	haplotype,normal_artifact	GGT1	NM_001288833.2	13	c.1305A>G	p.Val435=	synonymous_variant				COSV50638343	
	NEFH(35.5%)	exon4,c.1844C>T,p.P615L	0.355	0.291	26|18	5|1	0.30769	72|32	22	29885473	29885473	C	T	germline,normal_artifact	NEFH	NM_021076.4	4	c.1844C>T	p.Pro615Leu	missense_variant	Benign		Amyotrophic_lateral_sclerosis_type_1|Charcot-Marie-Tooth_disease_axonal_type_2CC|not_specified|not_provided		
	NEFH(10.9%)	exon4,c.1965_1989delinsTGAGAAGGCCAAGTCCCCA,p.E658_E659del	0.109	0.1	86|9	11|0	0.05528	188|11	22	29885594	29885618	AGAGAAGGAAGAGGCCAAGTCCCCT	TGAGAAGGCCAAGTCCCCA	PASS	NEFH	NM_021076.4	4	c.1965_1989delinsTGAGAAGGCCAAGTCCCCA	p.Glu658_Glu659del	missense_variant&conservative_inframe_deletion	Likely_benign		not_provided|NEFH-related_disorder		
	CDC42EP1(20.6%)	exon3,c.762_782del,p.P255_A261del	0.206	0.401	45|9	2|1	0.20000	36|9	22	37964408	37964429	CCAGCGCCTGCTGCAAACCCCT	C	germline,normal_artifact	CDC42EP1	NM_152243.3	3	c.762_782del	p.Pro255_Ala261del	disruptive_inframe_deletion					
	SOX10(83.3%)	exon4,c.927T>C,p.H309=	0.833	0.8	0|4	0|3	1.00000	0|4	22	38369976	38369976	A	G	germline,normal_artifact	SOX10	NM_006941.4	4	c.927T>C	p.His309=	synonymous_variant	Benign		Waardenburg_syndrome|not_specified|not_provided|Waardenburg_syndrome_type_2E|PCWH_syndrome|Waardenburg_syndrome_type_4C		
	AR(80.6%)	exon1,c.237_239dup,p.Q80dup	0.806	0.779	2|12	0|2	0.46429	15|13	X	66765158	66765158	T	TGCA	germline,normal_artifact,distinguished	AR	NM_000044.6	1	c.237_239dup	p.Gln80dup	disruptive_inframe_insertion	Benign/Likely_benign		not_provided|not_specified|Androgen_resistance_syndrome|Kennedy_disease		
	AR(84.1%)	exon1,c.1388_1420del,p.G463_G473del	0.841	0.75	0|4	0|2	*	0|0	X	66766356	66766389	TGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGC	T	germline,normal_artifact	AR	NM_000044.6	1	c.1388_1420del	p.Gly463_Gly473del	disruptive_inframe_deletion	Conflicting_classifications_of_pathogenicity	Uncertain_significance(1)|Benign(1)	AR-related_condition|Androgen_resistance_syndrome|Kennedy_disease		
	ATRX(10.3%)	exon12,c.4057G>A,p.G1353R	0.103	0.25	30|4	2|0	0.11429	31|4	X	76918934	76918934	C	T	PASS	ATRX	NM_000489.6	12	c.4057G>A	p.Gly1353Arg	missense_variant					
	ATRX(3.0%)	exon9,c.1033G>A,p.A345T	0.03	0.025	200|4	44|0	0.01739	226|4	X	76939715	76939715	C	T	distinguished	ATRX	NM_000489.6	9	c.1033G>A	p.Ala345Thr	missense_variant	Conflicting_classifications_of_pathogenicity	Uncertain_significance(1)|Benign(1)|Likely_benign(3)	not_provided|Inborn_genetic_diseases|Alpha_thalassemia-X-linked_intellectual_disability_syndrome		
